PharmiWeb13m
Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options
VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its exclusively-licensed ...
PharmiWeb2h
NextGen Healthcare Named Top Physician Practice Management Vendor by Black Book Research(TM)
NEW YORK CITY, NEW YORK / ACCESSWIRE / January 8, 2025 / Black Book™ Market Research LLC, a leading provider of healthcare IT insights, has announced the results of its annual Ambulatory EHR/Practice ...
PharmiWeb15h
tiakis Biotech AG Receives Positive Scientific Advice from the U.S. FDA for Planned Phase II Trial of Tiprelestat
Stanford University are preparing for a Phase II in Pulmonary Arterial Hypertension (PAH)Kiel, Germany, January 8, 2025 – ...
PharmiWeb15h
Coulter Partners places seasoned life sciences and CRO leader as CEO of Metrion Biosciences
Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...
PharmiWeb4h
NHI Announces Updates to Corporate Governance
MURFREESBORO, TN / ACCESSWIRE / January 8, 2025 / National Health Investors, Inc. (NYSE:NHI) announced a series of changes to the Board of Directors which enhances the Board's ability to provide ...
PharmiWeb18h
PhenQ Reviews: Legit Fat Burner Supplement or Scam Weight Loss Pills?
PhenQ is a natural weight management system that targets five major areas of metabolic health, providing a holistic solution for anyone trying to lose weight.  Summer season is loved and hated in ...
PharmiWeb8h
BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease
BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE ...
PharmiWeb12h
Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase
SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will participate in a virtual fireside ...
PharmiWeb12h
Formycon and Fresenius Kabi Canada receive Health…
Regulatory ApprovalFormycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 08.01.2025 / 14:30 CET/CESTThe issuer is solely ...
PharmiWeb10h
Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations
ZAGENO Forms a Strategic Partnership With Hatch.Bio Labs, a Premier Biotech Incubator Online, January 8, 2025 (Newswire.com) - ...
PharmiWeb15h
Medidata Signs Multi-Year Agreement with Bristol Myers Squibb to Extend Relationship and Continue Company’s Use of Platform
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that it has extended and expanded its partnership with Bristol Myers ...
PharmiWeb12h
The 2025 Black Book of Physician Practice Management Technology Released: A Competitive Intelligence Report
Free to participants in the 2025 survey of PM software, this comprehensive report offers critical insights into trends, developments, and vendor capabilities shaping the future of practice management.